1. Home
  2. THRY vs TTRX Comparison

THRY vs TTRX Comparison

Compare THRY & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thryv Holdings Inc.

THRY

Thryv Holdings Inc.

HOLD

Current Price

$3.83

Market Cap

114.8M

Sector

Industrials

ML Signal

HOLD

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$3.77

Market Cap

107.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
THRY
TTRX
Founded
2012
2015
Country
United States
United States
Employees
N/A
2
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.8M
107.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
THRY
TTRX
Price
$3.83
$3.77
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$9.33
$8.00
AVG Volume (30 Days)
742.1K
24.2K
Earning Date
04-30-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
100.50
N/A
EPS
0.10
N/A
Revenue
$785,015,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$36.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.91
$2.57
52 Week High
$15.49
$5.98

Technical Indicators

Market Signals
Indicator
THRY
TTRX
Relative Strength Index (RSI) 63.60 61.83
Support Level $3.46 $3.55
Resistance Level $4.05 $4.01
Average True Range (ATR) 0.29 0.22
MACD 0.07 0.04
Stochastic Oscillator 66.74 95.45

Price Performance

Historical Comparison
THRY
TTRX

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: